Lundbeck Foundation
Overview
The Lundbeck Foundation is a Danish enterprise foundation established in 1954. It acts as a long-term strategic owner of several healthcare companies, including a majority stake in H. Lundbeck A/S. The foundation's investment activities are managed through distinct arms, including Lundbeckfonden BioCapital for early-stage biotech investments and Lundbeckfonden Invest for a diversified portfolio of financial assets. The foundation's purpose is to generate returns from its commercial activities to provide philanthropic grants, primarily for biomedical and neuroscience research in Denmark. Its investment focus is on high-quality companies with strong leadership and long-term growth potential.
Portfolio Companies
7
Website
lundbeckfonden.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Ferrosan Medical Devices | Sep 2022 | Buyout/LBO | Co-investor |
| NMD Pharma | Feb 2022 | Series B | Co-investor |
| LEXEO Therapeutics | Sep 2021 | Series B | Co-investor |
| LEXEO Therapeutics | Jan 2021 | Series A | Co-investor |
| Enterome | Jan 2018 | Series D | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.